Halozyme Therapeutics Inc (NASDAQ:HALO)

Delayed Data
As of Sep 21
 -0.05 / -0.12%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Halozyme Therapeutics Inc have a median target of 53.50, with a high estimate of 66.00 and a low estimate of 17.00. The median estimate represents a +29.92% increase from the last price of 41.18.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in Halozyme Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -30.25%
Growthannually 81.32%


Growthquarterly -21.56%
Growthannually 64.49%
Key to the earnings and sales forecast charts.